MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt,
[News Source]
[News Source]
Blogosphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg


